Announced Fri, 24 Jul · 13:41 IST
Q1 FY27 results: PAT up 27%, INR 5 dividend declared, Ghana acquisition
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+7.7%1-day move
₹1690.10
prior close
₹1693.30
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.0-0.3+0.0+0.6+7.7—————————
Up moveDown movePending
AI summary
Q1 FY27 consolidated revenue rose 19% YoY to INR 7,977M; PAT grew 27% to INR 1,705M. Board declared INR 5 per share interim dividend (record date July 30). Granted 119,300 stock options under RSU Plan 2025. Subsidiary to acquire 80% stake in Ghana-based Sunshine Healthcare for up to GHS 45.6M (about INR 380M) and 30% stake in Neuome Technologies for up to INR 35M. Auditor Deloitte issued unmodified review opinion.
Likely market impact
Strong quarter with double-digit revenue and 27% PAT growth plus dividend; Ghana and Neuome deals signal international and tech-focused expansion.